A moderated debate between John Mandrola and EARLY TAVR investigator David Cohen on the early treatment of patients with ...
In this week’s edition of InnovationRx, we look at Town Hall Ventures’ $440 million haul, the CDC’s “Friday night massacre,” Boehringer’s new lung drug, and more.
Can Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback